SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-176532
Filing Date
2019-06-19
Accepted
2019-06-19 16:45:56
Documents
7
Period of Report
2019-06-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d765457d8k.htm 8-K 26798
2 EX-10.1 d765457dex101.htm EX-10.1 60966
3 EX-10.2 d765457dex102.htm EX-10.2 32767
4 EX-10.3 d765457dex103.htm EX-10.3 28395
5 EX-10.4 d765457dex104.htm EX-10.4 41717
6 EX-10.5 d765457dex105.htm EX-10.5 40332
7 EX-10.6 d765457dex106.htm EX-10.6 39096
  Complete submission text file 0001193125-19-176532.txt   271497
Mailing Address 955 MASSACHUSETTS AVENUE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 955 MASSACHUSETTS AVENUE 4TH FLOOR CAMBRIDGE MA 02139 857-529-8300
X4 Pharmaceuticals, Inc (Filer) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38295 | Film No.: 19906492
SIC: 2836 Biological Products, (No Diagnostic Substances)